Viviane Maura Rubert, Rafaela Gageiro Luchesi Soares, Fernanda Mambrini Só e Silva, Isabella Knorr Velho, M. Werlang, Tammy Shults, Jennifer Vann, Â. Bós
{"title":"Characteristics of polypharmacy in nonagenarians and centenarians","authors":"Viviane Maura Rubert, Rafaela Gageiro Luchesi Soares, Fernanda Mambrini Só e Silva, Isabella Knorr Velho, M. Werlang, Tammy Shults, Jennifer Vann, Â. Bós","doi":"10.22563/2525-7323.2023.v8.n.3.p.38-47","DOIUrl":null,"url":null,"abstract":"Introduction: Nonagenarians and centenarians are often affected by multiple morbidities that require the concomitant use of several drugs. Polypharmacy is defined as the consumption of five or more drugs and poses a cautionary challenge in healthcare. It is important to ensure the correct and safe use of medications. Objectives: To study the sociodemographic and clinical characteristics of polypharmacy in nonagenarians and centenarians. Methods: The location of the descriptive, cross-sectional, retrospective study was in the capital of the southern region of Brazil. A total of 243 nonagenarians and centenarians were evaluated between June 2016 to November 2016. Results: A total of 1450 medications were identified, corresponding to 5.9 ±2.87 medications perparticipant. Among the participants, 163 (67%) were considered as polypharmacy. The frequency of polypharmacy was higher than most reports in the literature, related to poor vision (74.18%, p=0.025), a history of cardiovascular diseases (78.00%, p<0.001), gastric diseases (77.33%, p=0.023), anxiety (80.00%, p=0.041), respiratory diseases (83.33%, p=0.014), arthrosis (76.53, p=0.010), thyroid disease (82.00%, p=0.012), symptoms of xerostomia (75.65%, p=0.008), dyspnea (78.85%, p=0.042), wheezing (81.10%, p=0.049), and fear of falling (72.90%, p=0.049). Conclusion: We concluded that polypharmacy is a prevalent phenomenon among nonagenarians andcentenarians; importance of sociodemographic and clinical characteristics must be taken into consideration when providing primary healthcare to this population.","PeriodicalId":110294,"journal":{"name":"JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA","volume":"108 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22563/2525-7323.2023.v8.n.3.p.38-47","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Nonagenarians and centenarians are often affected by multiple morbidities that require the concomitant use of several drugs. Polypharmacy is defined as the consumption of five or more drugs and poses a cautionary challenge in healthcare. It is important to ensure the correct and safe use of medications. Objectives: To study the sociodemographic and clinical characteristics of polypharmacy in nonagenarians and centenarians. Methods: The location of the descriptive, cross-sectional, retrospective study was in the capital of the southern region of Brazil. A total of 243 nonagenarians and centenarians were evaluated between June 2016 to November 2016. Results: A total of 1450 medications were identified, corresponding to 5.9 ±2.87 medications perparticipant. Among the participants, 163 (67%) were considered as polypharmacy. The frequency of polypharmacy was higher than most reports in the literature, related to poor vision (74.18%, p=0.025), a history of cardiovascular diseases (78.00%, p<0.001), gastric diseases (77.33%, p=0.023), anxiety (80.00%, p=0.041), respiratory diseases (83.33%, p=0.014), arthrosis (76.53, p=0.010), thyroid disease (82.00%, p=0.012), symptoms of xerostomia (75.65%, p=0.008), dyspnea (78.85%, p=0.042), wheezing (81.10%, p=0.049), and fear of falling (72.90%, p=0.049). Conclusion: We concluded that polypharmacy is a prevalent phenomenon among nonagenarians andcentenarians; importance of sociodemographic and clinical characteristics must be taken into consideration when providing primary healthcare to this population.